Jason A. Leverone

Chief Financial Officer, OnKure Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.0M

Companies

Latest trade

Sep 21, 2026

Companies

OnKure Therapeutics, Inc.Chief Financial Officer −$0.0M

Trades

OKUR Sold 302 shares at $2.97 $0.0M Sep 21

OKUR Sold 303 shares at $4.40 $0.0M Jun 22

OKUR Sold 301 shares at $4.16 $0.0M Mar 23

OKUR Sold 302 shares at $2.97 $0.0M Dec 22

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.